A binding analysis based on nitrocellulose filters and DNase I footprinting revealed that damaged DNA can serve as a competitive binding site for TBP, thereby distracting it from the promoter’s TATA box and thus delaying nucleotide excision repair, inhibiting RNA synthesis, and causing tumor cell death during cancer treatment. The gene discussed is TBP; the disease is cancer.